Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: A systematic review and meta-analysis

Gynecological Endocrinology

Volumn 29, Issue 4, 2013, Pages 278-284

  Fan, Wei ^a   Li, Shangwei ^a   Chen, Qiong ^a   Huang, Zhongying ^a   Ma, Qianhong ^a   Wang, Yan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

IVF; Meta analysis, poor responders; RLH

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN AGONIST; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; RECOMBINANT PROTEIN;

ARTICLE; BODY MASS; EMBRYO TRANSFER; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; META ANALYSIS; OOCYTE; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; FEMALE; METHODOLOGY; OVULATION INDUCTION; PREGNANCY; REVIEW;

FEMALE; FERTILIZATION IN VITRO; HUMANS; LUTEINIZING HORMONE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 84883178198     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.743016     Document Type: Article

References (34)

1. Keay SD, Liversedge NH, Mathur RS, Jenkins JM. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997;104:521-7.
2. Toner JP, Philput CB, Jones GS, Muasher SJ. Basal folliclestimulat-ing hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784-91.
3. Wardle PG, Mitchell JD, McLaughlin EA, et al. Endometriosis and ovulatory disorder: reduced fertilization in vitro compared with tubal and unexplained infertility. Lancet 1985;2:236-9.
4. Keay SD, Liversedge NH, Jenkins JM. Could ovarian infection impair ovarian response to gonadotrophin stimulation? Br J Obstet Gynaecol 1998;105:252-3.
5. Ben-Rafael Z, Strauss 3rd JF, Mastroianni Jr L, Flickinger GL. Differences in ovarian stimulation in human menopausal gonado-trophin treated woman may be related to follicle-stimulating hormone accumulation. Fertil Steril 1986;46:586-92.
6. Pandian Z, McTavish AR, Aucott L, et al. Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev 2010;20:CD004379.
7. Howles CM, Loumaye E, Germond M, et al. Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization? Hum Reprod 1999;14:1939-43.
8. Lok IH, Yip SK, Cheung LP, et al. Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial. Fertil Steril 2004;81:556-61.
9. Sunkara SK, Pundir J, Khalaf Y. Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis. Reprod Biomed Online 2011;22:545-55.
10. Placido GD, Alviggi C, Mollo A, et al. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation. Clin Endocrinol (Oxf) 2004;60:637-43.
11. Fleming R, Lloyd F, Herbert M, et al. Effect of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function inj cycles stimulated with purified follicle stimulating hormone. Hum Reprod 1998; 13:1788-92.
12. Westergaard JG, Erb K, Laursen SB, et al. Human menopausal gonadotropin versus recombinant follicle stimulating hormone in normogonadotropic women down-regulated with a gonadotropinre-leasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmatic spoerm injection: a prospective randomised study. Fertil Steril 2001;76:543-9.
13. Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 2000;15:1003-8.
14. Mochtar MH, Van der Veen Ziech M, van Wely M. Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev 2007;18:CD005070.
15. Loutradis D, Vomvolaki E, Drakakis P, et al. Poor responder protocols for in-vitro fertilization: options and results. Curr Opin Obstetr Gynecol 2008;20:374-8.
16. Kavvoura FK, Ioannidis JP. CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol 2005;162:3-16.
17. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820-6.
18. Ferraretti AP, Gianaroli L, Magli MC, et al. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 2004;82:1521-6.
19. De Placido G, Alviggi C, Perino A, et al. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonado-trophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 2005;20:390-6.
20. Barrenetxea G, Agirregoikoa JA, Jiménez MR, et al. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 2008;89:546-53.
21. Musters AM, van Wely M, Mastenbroek S, et al. The effect of recombinant LH on embryo quality: a randomized controlled trial in women with poor ovarian reserve. Hum Reprod 2012;27:244-50.
22. Chung K, Krey L, Katz J, Noyes N. Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists. Fertil Steril 2005;84:313-8.
23. Tarlatzis B, Tavmergen E, Szamatowicz M, et al. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study. Hum Reprod 2006;21:90-4.
24. Penarrubia J, Fabregues F, Creus M, et al. LH serum levels during ovarian stimultion as predictors of ovarian response and assisted reproduction outcome in down-regulated women estimulated with recombinant FSH. Hum Reprod 2003;18:2689-97.
25. Kolibianakis EM, Kalogeropoulou L, Griesinger G, et al. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Hum Reprod Update 2007;13:445-52.
26. Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders. Fertil Steril 2007;88:665-9.
27. Fabregues F, Creus M, Penarrubia J, et al. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age. Fertil Steril 2006; 85:925-31.
28. Hughes EG. Systematic literature review and meta-analysis. Semin Reprod Endocrinol 1996;14:161-9.
29. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-based medicine working group. JAMA 1993;270:2598-601.
30. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
31. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352:609-13.
32. Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001;323:42-6.
33. Cohlen BJ, Vandekerckhove P, te Velde ER, Habbema JD. Timed intercourse versus intra-uterine insemination with or without ovarian hyperstimulation for subfertility in men. Cochrane Database Syst Rev 2000;(2):CD000360.
34. Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26:1616-24.